AAAAAA

   
Results: 1-25 | 26-39
Results: 1-25/39
Doxorubicin, to treat cancers or to cause cardiac injury, that is the question
Authors: Kitakaze, M
Citation: M. Kitakaze, Doxorubicin, to treat cancers or to cause cardiac injury, that is the question, CARDIO DRUG, 15(3), 2001, pp. 199-200
Benidipine, a long-acting Ca channel blocker, limits infarct size via bradykinin- and NO-Dependent mechanisms in canine hearts
Authors: Asanuma, H Kitakaze, M Node, K Takashima, S Sakata, Y Asakura, M Sanada, S Shinozaki, Y Mori, H Tada, M Kuzuya, T Hori, M
Citation: H. Asanuma et al., Benidipine, a long-acting Ca channel blocker, limits infarct size via bradykinin- and NO-Dependent mechanisms in canine hearts, CARDIO DRUG, 15(3), 2001, pp. 225-231
cDNA array hybridization reveals cardiac gene expression in acute ischemicmurine hearts
Authors: Kitakaze, M Asakura, M Sakata, Y Asanuma, H Sanada, S Kuzuya, T Miyazaki, J Takashima, S Hori, M
Citation: M. Kitakaze et al., cDNA array hybridization reveals cardiac gene expression in acute ischemicmurine hearts, CARDIO DRUG, 15(2), 2001, pp. 125-130
Metabolism of hepatocyte growth factor in the heart in patients with coronary artery disease: Implication for coronary arteriosclerosis
Authors: Watanabe, K Fukuda, H Sueda, S Funada, J Kitakaze, M Sekiya, M
Citation: K. Watanabe et al., Metabolism of hepatocyte growth factor in the heart in patients with coronary artery disease: Implication for coronary arteriosclerosis, CARDIO DRUG, 15(2), 2001, pp. 147-153
Predictive factors for development of the no-reflow phenomenon in patientswith reperfused anterior wall acute myocardial infarction
Authors: Iwakura, K Ito, H Kawano, S Shintani, Y Yamamoto, K Kato, A Ikushima, M Tanaka, K Kitakaze, M Hori, M Higashino, Y Fujii, K
Citation: K. Iwakura et al., Predictive factors for development of the no-reflow phenomenon in patientswith reperfused anterior wall acute myocardial infarction, J AM COL C, 38(2), 2001, pp. 472-477
Role of mitochondrial and sarcolemmal K-ATP channels in ischemic preconditioning of the canine heart
Authors: Sanada, S Kitakaze, M Asanuma, H Harada, K Ogita, H Node, K Takashima, S Sakata, Y Asakura, M Shinozaki, Y Mori, H Kuzuya, T Hori, M
Citation: S. Sanada et al., Role of mitochondrial and sarcolemmal K-ATP channels in ischemic preconditioning of the canine heart, AM J P-HEAR, 280(1), 2001, pp. H256-H263
Nifedipine limits infarct size via NO-dependent mechanisms in dogs
Authors: Asanuma, H Kitakaze, M Funaya, H Takashima, S Minamino, T Node, K Sakata, Y Asakura, M Sanada, S Shinozaki, Y Mori, H Kuzuya, T Tada, M Hori, M
Citation: H. Asanuma et al., Nifedipine limits infarct size via NO-dependent mechanisms in dogs, BAS R CARD, 96(5), 2001, pp. 497-505
Differential subcellular actions of ACE inhibitors and AT(1) receptor antagonists on cardiac remodeling induced by chronic inhibition of NO synthesisin rats
Authors: Sanada, S Kitakaze, M Node, K Takashima, S Ogai, A Asanuma, H Sakata, Y Asakura, M Ogita, H Liao, YL Fukushima, T Yamada, J Minamino, T Kuzuya, T Hori, M
Citation: S. Sanada et al., Differential subcellular actions of ACE inhibitors and AT(1) receptor antagonists on cardiac remodeling induced by chronic inhibition of NO synthesisin rats, HYPERTENSIO, 38(3), 2001, pp. 404-411
Dynamic change in collateral flow associated with myocardial ischemia in humans
Authors: Sakata, Y Kitakaze, M Ishikura, F Lim, YJ Hirayama, A Kodama, K Masuyama, T Kuzuya, T Hori, M
Citation: Y. Sakata et al., Dynamic change in collateral flow associated with myocardial ischemia in humans, INT J CARD, 80(2-3), 2001, pp. 153-160
Role of cellular acidosis in production of nitric oxide in canine ischemicmyocardium
Authors: Kitakaze, M Node, K Takashima, S Asanuma, H Asakura, M Sanada, S Shinozaki, Y Mori, H Sato, H Kuzuya, T Hori, M
Citation: M. Kitakaze et al., Role of cellular acidosis in production of nitric oxide in canine ischemicmyocardium, J MOL CEL C, 33(9), 2001, pp. 1727-1737
Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy
Authors: Takemoto, M Node, K Nakagami, H Liao, YL Grimm, M Takemoto, Y Kitakaze, M Liao, JK
Citation: M. Takemoto et al., Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy, J CLIN INV, 108(10), 2001, pp. 1429-1437
Role of phasic dynamism of p38 mitogen-activated protein kinase activationin ischemic preconditioning of the canine heart
Authors: Sanada, S Kitakaze, M Papst, PJ Hatanaka, K Asanuma, H Aki, T Shinozaki, Y Ogita, H Node, K Takashima, S Asakura, M Yamada, J Fukushima, T Ogai, A Kuzuya, T Mori, H Terada, N Yoshida, K Hori, M
Citation: S. Sanada et al., Role of phasic dynamism of p38 mitogen-activated protein kinase activationin ischemic preconditioning of the canine heart, CIRCUL RES, 88(2), 2001, pp. 175-180
Cardioprotective effect afforded by transient exposure to phosphodiesterase III inhibitors - The role of protein kinase A and p38 mitogen-activated protein kinase
Authors: Sanada, S Kitakaze, M Papst, PJ Asanuma, H Node, K Takashima, S Asakura, M Ogita, H Liao, YL Sakata, Y Ogai, A Fukushima, T Yamada, J Shinozaki, Y Kuzuya, T Mori, H
Citation: S. Sanada et al., Cardioprotective effect afforded by transient exposure to phosphodiesterase III inhibitors - The role of protein kinase A and p38 mitogen-activated protein kinase, CIRCULATION, 104(6), 2001, pp. 705-710
Adenosine therapy: a new approach to chronic heart failure
Authors: Kitakaze, M Hori, M
Citation: M. Kitakaze et M. Hori, Adenosine therapy: a new approach to chronic heart failure, EXPERT OP I, 9(11), 2000, pp. 2519-2535
Inhibition of nitric oxide synthesis induces coronary vascular remodeling and cardiac hypertrophy associated with the activation of p70 S6 kinase in rats
Authors: Minamino, T Kitakaze, M Papst, PJ Ueda, Y Sakata, Y Asanuma, H Ogai, A Kuzuya, T Terada, N Hori, M
Citation: T. Minamino et al., Inhibition of nitric oxide synthesis induces coronary vascular remodeling and cardiac hypertrophy associated with the activation of p70 S6 kinase in rats, CARDIO DRUG, 14(5), 2000, pp. 533-542
Chronic treatment with FK506 increases p70 s6 kinase activity associated with reduced nitric oxide synthase activity in rabbit hearts
Authors: Minamino, T Kitakaze, M Ueda, Y Asanuma, H Papst, PJ Kuzuya, T Terada, N Hori, M
Citation: T. Minamino et al., Chronic treatment with FK506 increases p70 s6 kinase activity associated with reduced nitric oxide synthase activity in rabbit hearts, CARDIO DRUG, 14(3), 2000, pp. 329-336
Cellular mechanisms of cardioprotection afforded by inhibitors of angiotensin converting enzyme in ischemic hearts: Role of bradykinin and nitric oxide
Authors: Kitakaze, M Node, K Takashima, S Minamino, T Kuzuya, T Hori, M
Citation: M. Kitakaze et al., Cellular mechanisms of cardioprotection afforded by inhibitors of angiotensin converting enzyme in ischemic hearts: Role of bradykinin and nitric oxide, HYPERTENS R, 23(3), 2000, pp. 253-259
Cardioprotective effect of diadenosine tetraphosphate (AP4A) preservation in hypothermic storage and its relation with mitochondrial ATP-sensitive potassium channels
Authors: Ahmet, I Sawa, Y Nishimura, M Kitakaze, M Matsuda, H
Citation: I. Ahmet et al., Cardioprotective effect of diadenosine tetraphosphate (AP4A) preservation in hypothermic storage and its relation with mitochondrial ATP-sensitive potassium channels, TRANSPLANT, 69(1), 2000, pp. 16-20
Protein tyrosine kinase is not involved in the infarct size-limiting effect of ischemic preconditioning in canine hearts
Authors: Kitakaze, M Node, K Asanuma, H Takashima, S Sakata, Y Asakura, M Sanada, S Shinozaki, Y Mori, H Kuzuya, T Hori, M
Citation: M. Kitakaze et al., Protein tyrosine kinase is not involved in the infarct size-limiting effect of ischemic preconditioning in canine hearts, CIRCUL RES, 87(4), 2000, pp. 303-308
Nifedipine-induced coronary vasodilation in ischemic hearts is attributable to bradykinin- and NO-dependent mechanisms in dogs
Authors: Kitakaze, M Asanuma, H Takashima, S Minamino, T Ueda, Y Sakata, Y Asakura, M Sanada, S Kuzuya, T Hori, M
Citation: M. Kitakaze et al., Nifedipine-induced coronary vasodilation in ischemic hearts is attributable to bradykinin- and NO-dependent mechanisms in dogs, CIRCULATION, 101(3), 2000, pp. 311-317
Ecto-5 '-nucleotidase plays a role in the cardioprotective effects of heatshock protein 72 in ischemia-reperfusion injury in rat hearts
Authors: Sakaguchi, T Sawa, Y Kitakaze, M Suzuki, K Nishimura, M Kaneda, Y Matsuda, H
Citation: T. Sakaguchi et al., Ecto-5 '-nucleotidase plays a role in the cardioprotective effects of heatshock protein 72 in ischemia-reperfusion injury in rat hearts, CARDIO RES, 47(1), 2000, pp. 74-80
Myocardial protection using diadenosine tetraphosphate with pharmacological preconditioning
Authors: Ahmet, I Sawa, Y Nishimura, M Yamaguchi, T Kitakaze, M Matsuda, H
Citation: I. Ahmet et al., Myocardial protection using diadenosine tetraphosphate with pharmacological preconditioning, ANN THORAC, 70(3), 2000, pp. 901-905
Is adenosine preconditioning truly cardioprotective in coronary artery bypass surgery?
Authors: Belhomme, D Peynet, J Florens, E Tibourtine, O Kitakaze, M Menasche, P
Citation: D. Belhomme et al., Is adenosine preconditioning truly cardioprotective in coronary artery bypass surgery?, ANN THORAC, 70(2), 2000, pp. 590-594
Increased cardiac levels of nitric oxide in patients with chronic heart failure
Authors: Node, K Kitakaze, M Yoshihara, F Sasaki, T Kuzuya, T Hori, M
Citation: K. Node et al., Increased cardiac levels of nitric oxide in patients with chronic heart failure, AM J CARD, 86(4), 2000, pp. 474
Glycoprotein IIb/IIIa antagonist FK633 could not prevent neointimal thickening in stent implantation model of canine coronary artery
Authors: Ueda, Y Kitakaze, M Imakita, M Ishibashi-Ueda, H Minamino, T Asanuma, H Ozaki, T Imamura, E Kuzuya, T Hori, M
Citation: Y. Ueda et al., Glycoprotein IIb/IIIa antagonist FK633 could not prevent neointimal thickening in stent implantation model of canine coronary artery, ART THROM V, 19(2), 1999, pp. 343-347
Risultati: 1-25 | 26-39